---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-086882"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2026-03-03T23:59:59+00:00"
generated_at: "2026-05-15T22:15:15.324784+00:00"
event_type: "dividend"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "medium"
source: SEC EDGAR
---

# Jaguar Health files Series O Preferred Stock certificate for special dividend payable March 4

## Summary
- Filed Certificate of Designation for 1,557,000 shares of Series O Convertible Preferred Stock.
- Special dividend of 1/10th Series O share per common share + each of 2,400,765 eligible warrant shares; record date March 2.
- Series O has no dividends, limited voting rights, liquidation preference $0.0001/share, and conversion at Minimum Price by Dec 31, 2026.
- Transfer restricted without company consent; conversion limited to 19.99% beneficial ownership cap.
- No trading market for Series O; optional conversion by company or automatic conversion on Dec 31, 2026.

## SEC filing metadata
- accession: 0001193125-26-086882
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2026-03-03T23:59:59+00:00
- event_type: dividend
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: medium
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000119312526086882/0001193125-26-086882-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000119312526086882/d236488d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-086882
- JSON: https://secwatch.observer/filing/0001193125-26-086882.json
- Plain text: https://secwatch.observer/filing/0001193125-26-086882.txt

## Source-grounded claims
- claim_id: 9346eccd6bda3dcf16bd4e3fc120cfd6a446816c
  claim: Jaguar Health, Inc.: Filed Certificate of Designation for Series O Convertible Preferred Stock (effective 2026-03-02).
  evidence_excerpt: on March 2, 2026 the Company filed a Certificate of Designation of Preferences, Rights and Limitations of Series O Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, to designate 1,557,000 shares of the Company’s preferred stock, par value $0.0001 per share, as Series O Convertible Preferred Stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1585608/000119312526086882/0001193125-26-086882-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.